Vectorite Biomedical Inc. (TPEX:4170)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
13.75
-0.05 (-0.36%)
Apr 29, 2026, 1:57 PM CST
3.38%
Market Cap 601.86M
Revenue (ttm) 61.41M
Net Income (ttm) 96.17M
Shares Out 43.77M
EPS (ttm) 2.19
PE Ratio 6.28
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 38,369
Average Volume 72,864
Open 13.80
Previous Close 13.80
Day's Range 13.75 - 14.35
52-Week Range 11.45 - 18.15
Beta 0.44
RSI 48.28
Earnings Date May 4, 2026

About Vectorite Biomedical

Vectorite Biomedical Inc. engages in the research and development of biotechnology in Taiwan and internationally. It is involved in cell preparation product manufacturing; and collection and storage of immune cells. The company’s products are used in the field of infectious diseases and inflammation, cancer, oncology. Vectorite Biomedical Inc. was incorporated in 2004 and is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4170
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.